​

Aclarion Stock (NASDAQ:ACON)

RevenueOwnershipFinancialsChart
Aclarion by TradingView

Previous Close

$3.26

52W Range

$2.34 - $12.03

50D Avg

$3.13

200D Avg

$5.71

Market Cap

$1.76M

Avg Vol (3M)

$111.33K

Beta

1.14

Div Yield

-

ACON Company Profile

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

5

IPO Date

Apr 22, 2022

Website

ACON Performance

ACON Financial Summary

Dec 25Dec 24Dec 23
Revenue$75.73B$45.72K$75.40K
Operating Income$-7.05T$-5.51M$-4.88M
Net Income$-7.23T$-6.99M$-4.91M
EBITDA$-7.05T$-6.26M$-4.14M
Basic EPS$-13.61$-7.48K$-79.78K
Diluted EPS$-13.61$-7.48K$-79.78K

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
MSPRMSP Recovery, Inc.
BNBXBNB Plus Corp.
KZIAKazia Therapeutics Limited
SNGXSoligenix, Inc.
BFRGBullfrog AI Holdings, Inc. Common Stock
TTNPTitan Pharmaceuticals, Inc.
SILOSilo Pharma, Inc.
ENSCEnsysce Biosciences, Inc.
CMNDClearmind Medicine Inc.